Allovir, Inc. (ALVR)

Number of records: 50
SEC FilingInsiderCompanyTrade DateTransactionSharesAvg. PriceTotal% HoldingsReturn
05-Oct-21 9:05 PM
View: 
Melian Agustin
Chief Medical Officer
Allovir, Inc. (ALVR) 04-Oct-21Market Sale 18,689$23.91$446,862.00(4%)
472.22K to 453.53K
5%
01-Oct-21 5:58 PM
View: 
van Beek Jeroen B
Chief Commercial Officer
Allovir, Inc. (ALVR) 01-Oct-21Market Sale (Planned) 3,413$25.07$85,574.80(< 1%)
422.01K to 418.6K
< 1%
01-Oct-21 5:58 PM
View: 
van Beek Jeroen B
Chief Commercial Officer
Allovir, Inc. (ALVR) 30-Sep-21Market Sale (Planned) 12,171$25.17$306,294.00(3%)
434.18K to 422.01K
< 1%
01-Oct-21 5:58 PM
View: 
van Beek Jeroen B
Chief Commercial Officer
Allovir, Inc. (ALVR) 29-Sep-21Market Sale (Planned) 1,000$25.04$25,036.70(< 1%)
435.18K to 434.18K
(< 1%)
29-Sep-21 4:15 PM
View: 
Melian Agustin
Chief Medical Officer
Allovir, Inc. (ALVR) 28-Sep-21Market Sale (Planned) 3,750$24.12$90,432.40(< 1%)
475.97K to 472.22K
(2%)
20-Sep-21 6:33 PM
View: 
van Beek Jeroen B
Chief Commercial Officer
Allovir, Inc. (ALVR) 17-Sep-21Market Sale (Planned) 5,916$25.08$148,362.00(1%)
441.1K to 435.18K
4%
20-Sep-21 4:05 PM
View: 
Melian Agustin
Chief Medical Officer
Allovir, Inc. (ALVR) 17-Sep-21Market Sale (Planned) 2,950$24.01$70,841.90(< 1%)
478.92K to 475.97K
< 1%
20-Sep-21 4:05 PM
View: 
Melian Agustin
Chief Medical Officer
Allovir, Inc. (ALVR) 15-Sep-21Market Sale (Planned) 800$24.03$19,224.00(< 1%)
479.72K to 478.92K
< 1%
20-Sep-21 6:33 PM
View: 
van Beek Jeroen B
Chief Commercial Officer
Allovir, Inc. (ALVR) 02-Sep-21Market Sale 513$19.86$10,188.20(< 1%)
441.61K to 441.1K
(21%)
20-Sep-21 6:33 PM
View: 
van Beek Jeroen B
Chief Commercial Officer
Allovir, Inc. (ALVR) 17-Aug-21Market Sale 15,205$17.82$270,953.00(3%)
456.81K to 441.61K
(35%)
20-Sep-21 4:05 PM
View: 
Melian Agustin
Chief Medical Officer
Allovir, Inc. (ALVR) 02-Jul-21Market Sale 18,586$19.99$371,534.00(4%)
498.3K to 479.72K
(20%)
20-Sep-21 6:33 PM
View: 
van Beek Jeroen B
Chief Commercial Officer
Allovir, Inc. (ALVR) 03-Jun-21Market Sale 508$22.87$11,618.00(< 1%)
457.32K to 456.81K
(5%)
27-May-21 4:50 PM
View: 
Brenner Malcolm
Director
Allovir, Inc. (ALVR) 25-May-21Gift 818,663----(83%)
982.39K to 163.73K
20-Sep-21 6:33 PM
View: 
van Beek Jeroen B
Chief Commercial Officer
Allovir, Inc. (ALVR) 18-May-21Market Sale 15,201$22.80$346,583.00(3%)
472.52K to 457.32K
(5%)
18-May-21 5:08 PM
View: 
Brainard Diana
Chief Executive Officer
Director
Allovir, Inc. (ALVR) 17-May-21Grant 200,000----3175%
6.3K to 206.3K
10-May-21 5:28 PM
View: 
Leen Ann M.
Chief Scientific Officer
Allovir, Inc. (ALVR) 10-May-21Market Sale 150,000$22.75$3,412,500.00(6%)
2.49M to 2.34M
(5%)
20-Sep-21 4:05 PM
View: 
Melian Agustin
Chief Medical Officer
Allovir, Inc. (ALVR) 05-Apr-21Market Sale 18,212$23.89$435,085.00(4%)
516.52K to 498.3K
(< 1%)
24-Mar-21 4:53 PM
View: 
Melian Agustin
Chief Medical Officer
Allovir, Inc. (ALVR) 22-Mar-21Market Sale (Planned) 3,750$25.97$97,393.50(< 1%)
520.27K to 516.52K
11%
18-Mar-21 5:08 PM
View: 
Leen Ann M.
Chief Scientific Officer
Allovir, Inc. (ALVR) 16-Mar-21Market Sale (Planned) 3,025$30.00$90,750.90(< 1%)
2.49M to 2.49M
7%
11-Mar-21 4:43 PM
View: 
Wilson John Robert
Director
Allovir, Inc. (ALVR) 11-Mar-21Market Sale (Planned) 16,662$31.01$516,729.00(< 1%)
8.59M to 8.58M
< 1%
11-Mar-21 4:43 PM
View: 
Wilson John Robert
Director
Allovir, Inc. (ALVR) 10-Mar-21Market Sale (Planned) 72,745$31.26$2,273,920.00(< 1%)
8.67M to 8.59M
< 1%
11-Mar-21 4:43 PM
View: 
Wilson John Robert
Director
Allovir, Inc. (ALVR) 09-Mar-21Market Sale (Planned) 110,595$31.44$3,477,450.00(1%)
8.78M to 8.67M
1%
08-Mar-21 4:12 PM
View: 
Brenner Malcolm
Director
Allovir, Inc. (ALVR) 05-Mar-21Market Sale (Planned) 48,091$31.10$1,495,500.00(5%)
896.95K to 848.86K
2%
08-Mar-21 4:12 PM
View: 
Brenner Malcolm
Director
Allovir, Inc. (ALVR) 04-Mar-21Market Sale (Planned) 49,598$35.83$1,777,300.00(5%)
946.55K to 896.95K
15%
03-Mar-21 8:36 PM
View: 
Vera Juan
Director
Allovir, Inc. (ALVR) 03-Mar-21Market Sale (Planned) 15,988$38.32$612,585.00(< 1%)
2.36M to 2.34M
3%
03-Mar-21 8:34 PM
View: 
Brenner Malcolm
Director
Allovir, Inc. (ALVR) 03-Mar-21Market Sale (Planned) 17,915$37.95$679,950.00(2%)
964.46K to 946.55K
2%
20-Sep-21 6:33 PM
View: 
van Beek Jeroen B
Chief Commercial Officer
Allovir, Inc. (ALVR) 02-Mar-21Market Sale 512$37.93$19,420.20(< 1%)
473.03K to 472.52K
37%
03-Mar-21 8:36 PM
View: 
Vera Juan
Director
Allovir, Inc. (ALVR) 02-Mar-21Market Sale (Planned) 14,994$38.11$571,396.00(< 1%)
2.37M to 2.36M
3%
03-Mar-21 8:34 PM
View: 
Brenner Malcolm
Director
Allovir, Inc. (ALVR) 02-Mar-21Market Sale (Planned) 12,658$38.11$482,388.00(1%)
977.12K to 964.46K
3%
03-Mar-21 8:34 PM
View: 
Brenner Malcolm
Director
Allovir, Inc. (ALVR) 01-Mar-21Market Sale (Planned) 21,694$38.64$838,227.00(2%)
998.82K to 977.12K
4%
03-Mar-21 8:36 PM
View: 
van Beek Jeroen B
Chief Commercial Officer
Allovir, Inc. (ALVR) 01-Mar-21Market Sale (Planned) 5,932$38.78$230,034.00(1%)
494.16K to 488.23K
4%
03-Mar-21 8:34 PM
View: 
Leen Ann M.
Chief Scientific Officer
Allovir, Inc. (ALVR) 01-Mar-21Market Sale (Planned) 9,518$38.70$368,329.00(< 1%)
2.5M to 2.49M
4%
03-Mar-21 8:35 PM
View: 
Miller Edward
General Counsel
Allovir, Inc. (ALVR) 01-Mar-21Market Sale (Planned) 6,000$38.78$232,699.00(2%)
392.86K to 386.86K
4%
03-Mar-21 8:36 PM
View: 
Vera Juan
Director
Allovir, Inc. (ALVR) 01-Mar-21Market Sale (Planned) 32,854$38.59$1,267,780.00(1%)
2.4M to 2.37M
4%
23-Feb-21 7:43 PM
View: 
Leen Ann M.
Chief Scientific Officer
Allovir, Inc. (ALVR) 23-Feb-21Market Sale (Planned) 4,199$39.50$165,876.00(< 1%)
2.5M to 2.5M
6%
23-Feb-21 7:44 PM
View: 
Vera Juan
Director
Allovir, Inc. (ALVR) 23-Feb-21Market Sale (Planned) 8,850$39.40$348,684.00(< 1%)
2.41M to 2.4M
6%
23-Feb-21 7:42 PM
View: 
Brenner Malcolm
Director
Allovir, Inc. (ALVR) 23-Feb-21Market Sale (Planned) 8,489$39.47$335,036.00(< 1%)
1.01M to 998.82K
6%
23-Feb-21 7:44 PM
View: 
van Beek Jeroen B
Chief Commercial Officer
Allovir, Inc. (ALVR) 23-Feb-21Market Sale (Planned) 2,118$39.56$83,783.40(< 1%)
496.28K to 494.16K
6%
23-Feb-21 7:44 PM
View: 
Vera Juan
Director
Allovir, Inc. (ALVR) 22-Feb-21Market Sale (Planned) 14,321$42.57$609,614.00(< 1%)
2.43M to 2.41M
13%
23-Feb-21 7:42 PM
View: 
Brenner Malcolm
Director
Allovir, Inc. (ALVR) 22-Feb-21Market Sale (Planned) 11,423$42.57$486,246.00(1%)
1.02M to 1.01M
13%
23-Feb-21 7:43 PM
View: 
Hagen Brett R
Chief Accounting Officer
Allovir, Inc. (ALVR) 22-Feb-21Market Sale (Planned) 800$43.14$34,509.00(1%)
65.56K to 64.77K
14%
23-Feb-21 7:44 PM
View: 
van Beek Jeroen B
Chief Commercial Officer
Allovir, Inc. (ALVR) 22-Feb-21Market Sale (Planned) 2,800$42.54$119,118.00(< 1%)
499.08K to 496.28K
13%
23-Feb-21 7:43 PM
View: 
Leen Ann M.
Chief Scientific Officer
Allovir, Inc. (ALVR) 22-Feb-21Market Sale (Planned) 5,706$42.57$242,880.00(< 1%)
2.51M to 2.5M
13%
23-Feb-21 7:44 PM
View: 
van Beek Jeroen B
Chief Commercial Officer
Allovir, Inc. (ALVR) 19-Feb-21Market Sale (Planned) 4,165$41.71$173,720.00(< 1%)
503.25K to 499.08K
11%
23-Feb-21 7:43 PM
View: 
Leen Ann M.
Chief Scientific Officer
Allovir, Inc. (ALVR) 19-Feb-21Market Sale (Planned) 7,541$41.75$314,868.00(< 1%)
2.52M to 2.51M
11%
23-Feb-21 7:44 PM
View: 
Vera Juan
Director
Allovir, Inc. (ALVR) 19-Feb-21Market Sale (Planned) 13,233$41.79$553,011.00(< 1%)
2.44M to 2.43M
11%
23-Feb-21 7:42 PM
View: 
Brenner Malcolm
Director
Allovir, Inc. (ALVR) 19-Feb-21Market Sale (Planned) 11,990$41.78$500,935.00(1%)
1.03M to 1.02M
11%
19-Feb-21 8:44 AM
View: 
Hagen Brett R
Chief Accounting Officer
Allovir, Inc. (ALVR) 18-Feb-21Market Sale (Planned) 741$40.11$29,723.70(1%)
66.31K to 65.56K
7%
19-Feb-21 8:44 AM
View: 
Leen Ann M.
Chief Scientific Officer
Allovir, Inc. (ALVR) 18-Feb-21Market Sale (Planned) 2,700$40.81$110,194.00(< 1%)
2.52M to 2.52M
9%
23-Feb-21 7:57 PM
View: 
Bornstein Jeffrey S
Director
Allovir, Inc. (ALVR) 18-Feb-21Market Sale 20,583$40.43$832,119.00(41%)
50.78K to 30.2K
8%